Volume : VIII, Issue : XI, November - 2019
A Study of Oral Trenexamic Acid in treatment of Melasma patients
Dr. Teki Satya Sri, Dr. G. Prema Jyothi
Abstract :
Melasma is a common pigmentary disorder characterized by grey own macules and patches on sun exposed skin. Many treatment modalities which include bleaching agents like retinoids, topical corticosteroids or superficial peeling agents have been tried alone or in combinations. Introduction of trenaxamic acid is a new concept. 50 patients clinically diagnosed as melasma after Wood’s lamp examination were enrolled after taking informed consent. All patients were investigated for coagulation profile, complete blood picture and thyroid profile. Each patient was given oral trenaxamic acid 250 mg twice daily after food for 3months along with instructions to apply topical oad spectrum sunscreen three times a day. They were followed up once in a month for another 3 months. MASI score was calculated initially and at each visit. Results were assessed clinically, photographically and by patient satisfaction. Out of 50, 48 patients had excellent improvement. Response was seen within 2 months of initiation of therapy.
Keywords :
Article:
Download PDF
DOI : 10.36106/ijsr
Cite This Article:
A STUDY OF ORAL TRENEXAMIC ACID IN TREATMENT OF MELASMA PATIENTS, Dr. Teki Satya Sri, Dr. G.Prema Jyothi INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH : Volume-8 | Issue-11 | November-2019
Number of Downloads : 196
A STUDY OF ORAL TRENEXAMIC ACID IN TREATMENT OF MELASMA PATIENTS, Dr. Teki Satya Sri, Dr. G.Prema Jyothi INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH : Volume-8 | Issue-11 | November-2019
Our Other Journals...
-
Indian Journal of
Applied Research Visit Website -
PARIPEX Indian Journal
of Research Visit Website -
Global Journal for
Research Analysis Visit Website